1263198

Novartis Pharmaceuticals Corporation — FEI 2210396

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 3, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Hanover, NJ (United States)